Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE-CRYO: PolarX vs Arctic Front Cryoballoon for PVI in Paroxysmal AF
NCT04704986Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Insel Gruppe. Primary endpoint: Number of Patients With Recurrence of Any Atrial Tachyarrhythmia. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04704986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704986.